Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.
NCT00306696 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 388
Last updated 2016-09-15
Summary
Study examining the effect of different diuretics on fluid retention in diabetics treated with rosiglitazone.
Conditions
Interventions
- DRUG
-
Rosiglitazone
- DRUG
-
spironolactone
- DRUG
-
hydrochlorothiazide
- DRUG
-
frusemide
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 35 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-10-31
- Completion
- 2004-01-31
Countries
- Belgium
- Canada
- Denmark
- France
- Germany
- Greece
- Israel
- Italy
- Netherlands
- Norway
- Poland
- Slovakia
- Spain
- United Kingdom
Study Locations
More Related Trials
-
Hemodynamic Effects of Spironolactone in Patients With Heart Failure
NCT00860340 ·Status: COMPLETED ·Phase: NA
-
Comparison of Single and Combination Diuretics in Low-Renin Hypertension
NCT02351973 ·Status: UNKNOWN ·Phase: PHASE4
-
Mineralocorticoid Receptor and Obesity Induced Cardiovascular Complications
NCT01406015 ·Status: COMPLETED ·Phase: NA
-
Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure
NCT01667614 ·Status: COMPLETED ·Phase: PHASE2
-
Spironolactone for Reducing Proteinuria in Diabetic Nephropathy
NCT00498537 ·Status: COMPLETED ·Phase: NA
-
Spironolactone in the Treatment of Heart Failure
NCT04727073 ·Status: TERMINATED ·Phase: PHASE3
-
DAPAgliflozin Versus Thiazide Diuretic in Patients With Heart Failure and Diuretic RESISTance
NCT04860011 ·Status: UNKNOWN ·Phase: PHASE3
-
Protocolized Diuretic Strategy in Cardiorenal Failure
NCT01921829 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Acetazolamide on Diuresis and Natriuresis in Patients With Acute Heart Failure (SANDI STUDY)
NCT06285760 ·Status: RECRUITING
-
Acetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart Failure
NCT01973335 ·Status: COMPLETED ·Phase: PHASE4
-
Extracellular Fluid in Resistant Hypertension
NCT00141596 ·Status: TERMINATED ·Phase: NA
-
Comparing Diuretic Strategies in Hospitalized Heart Failure
NCT03999216 ·Status: WITHDRAWN ·Phase: PHASE4
-
Asian Diabetes Outcomes Prevention Trial
NCT04286399 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Spironolactone on Matrix Metalloproteinases (MMPs) in Heart Failure
NCT00663195 ·Status: COMPLETED ·Phase: PHASE4
-
Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing
NCT03746002 ·Status: TERMINATED ·Phase: PHASE4
-
The Efficacy of Spironolactone in Patients With Resistant Hypertension
NCT00430794 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
NCT00264927 ·Status: COMPLETED ·Phase: PHASE3
-
Diuretic and Natriuretic Effect of High-dose Spironolactone in Patients With Acute Heart Failure
NCT04618601 ·Status: UNKNOWN ·Phase: PHASE4
-
Double Blind Crossover Comparison of Diuretics in the Young
NCT00429897 ·Status: UNKNOWN ·Phase: NA
-
Spironolactone in Diabetic Nephropathy
NCT00317954 ·Status: COMPLETED ·Phase: PHASE4
-
Analysing the Effect of Empagliflozin on Reduction of Tissue Sodium Content in Patients With Chronic Heart Failure
NCT03128528 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of the Use of Dapagliflozin in Patients With Refractory Heart Failure
NCT06578520 ·Status: RECRUITING ·Phase: PHASE4
-
Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
NCT00865124 ·Status: COMPLETED ·Phase: NA
-
Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure
NCT02606253 ·Status: COMPLETED ·Phase: PHASE4
-
Antiremodeling Effect Of Aldosterone Receptors Blockade With Canrenone In Mild Chronic Heart Failure. AREA IN-CHF Study
NCT00403910 ·Status: COMPLETED ·Phase: PHASE3